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Awareness and perception of multidrug-resistant 
organisms and antimicrobial therapy among internists 
vs. surgeons of different specialties: Results from the 
German MR2 Survey 
 
Abstract 
Background: Recently, antibiotic resistance rates have risen substantially and care for 
patients infected with multidrug-resistant organisms (MDRO) has become a common 
problem in most in – and outpatient settings. The objectives of the study were to compare 
the awareness, perception, and knowledge of MDRO and rational antibiotic use between 
physicians from different medical specialties in German hospitals. 
Methods: A 35-item questionnaire was sent to specialists in internal medicine (internists), 
gynecologists, urologists, and general surgeons (non-internists) in 18 German hospitals. 
Likert-scales were used to evaluate awareness and perception of personal performance 
regarding care for patients infected with MDRO and rational use of antibiotics. 
Additionally, two items assessing specific knowledge in antibiotic therapy were included. 
The impact of medical specialty on four predetermined endpoints was assessed by 
multivariate logistic regression. 
Results: 43.0% (456/1061) of recipients responded. Both internists and non-internists had 
low rates of training in antibiotic stewardship. 50.8% of internists and 58.6% of non-
internists had attended special training in rational antibiotic use or care for patients 
infected with MDRO in the 12 months prior to the study. Internists deemed themselves 
more confidently to choose the indications for screening patients for colonization with 
methicillin-resistant Staphylococcus aureus (P=0.004) and to initiate adequate infection 
control measures (P=0.002) than other specialties. However, there was no significant 
difference between internists and other specialists regarding the two items assessing 
specific knowledge in antibiotic therapy and infection control. 
Conclusion: Among the study participants, a considerable need for advanced training in 
the study subjects was seen, regardless of the medical specialty. 
Keywords: Antibiotic Resistance; Antibiotic Policy; Antibiotic prescription; Multidrug 
Resistance; Urinary Tract Infection; Survey Study 
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The increasing rate of multidrug-resistant organisms (MDRO) worldwide poses a 
number of challenges in infection control and clinical management. The European Center 
for Disease Prevention and Control estimates that MDRO cause up to 25,000 deaths, costs 
of more than 1.5 billion Euro, and prolonged hospitalizations of more than 2.5 million days 
annually (1). To prevent further spread or transmission of these organisms, a number of 
infection control measures have been proposed by national bodies.  
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These measures include adequate screening of patients at 
risk to be colonized with these organisms, personal 
preventive measures (use of gloves and gowns in personal 
contact, contact isolation) and strict adherence to hand 
hygiene measures.  
Given that the inadequate prescription of broad-spectrum 
antibiotics fuel development and spread of antibiotic 
resistance, simultaneous strategies for a rational use of 
antibiotics are necessary (2). To maintain the efficacy of 
antibiotics and to reduce the development of resistance, 
knowledge regarding the targeted use of antibiotics is 
necessary (3, 4).  
However, several studies have shown high rates of 
inadequate prescription of antibiotics in a number of clinical 
situations (5-7). In a recent study, Hansen et al. estimated 
that approximately 40,000 evaluable patients in 132 German 
hospitals, around 40% were inadequately treated with 
antibiotic substances (7). 
Multiple national and international programs, such as the 
German Antimicrobial Resistance Strategy (DART 2020) by 
the German Federal Ministry of Health, were initiated to 
address this problem and facilitate training and research in 
this field (3). Antibiotic stewardship (ABS) programs have 
been developed to address these challenges. The Centers of 
Disease Control in the US has recommended that these 
programs should be initiated in every hospital for acute 
cases.  
A recent meta-analysis by the Cochrane collaboration 
demonstrated that the implementation of ABS programs is 
effective in reducing the use of inadequate antibiotic use and 
stated the potential of ABS programs to lower rates of 
MDRO and hospital-acquired infection (HAI) (4).  
In many countries, infectious diseases are a dedicated 
subspecialty of internal medicine. However, also general 
internists commonly prescribe antibiotics in a wide variety of 
clinical settings. Internists should therefore be particularly 
trained in the proper use of antibiotics to prevent inadequate 
use of antibiotics (8).  
To date, there are no studies that have evaluated the self-
reported perception of competence regarding MDRO and 
rational use of antibiotics in different clinical specialties. The 
aim of this study was to compare self-reported knowledge 
and awareness of MDRO or rather ABS between internists 
and surgical specialists using a questionnaire addressing 
different aspects of rational antibiotic use and multidrug 
resistant organisms. 
Methods 
Setting, participants, and survey instrument: The study 
group for developing and carrying out a self-administered 
questionnaire to evaluate the knowledge of different clinical 
specialties regarding MDRO and strategies of rational use of 
antibiotics (Multi-institutional Reconnaissance of practice 
with Multi-Resistant bacteria – a survey focusing on German 
hospitals: MR2) was founded in May 2015 and subsequently 
developed a questionnaire, which was tested and further 
refined in a pilot study with 15 clinicians representing all 
included medical specialties, as described previously (9, 10). 
MR2 survey study was approved by the Institutional Review 
Board of St.  
Elisabeth Hospital Straubing, which served as the central 
research coordinating facility. The questionnaire was 
addressed to internists, general surgeons, gynecologists, and 
urologists employed in German hospitals. 
To characterize the respondents, four items were used 
(hospital, specialty, hospital hierarchy, the frequency of 
antibiotic prescriptions within the preceding seven 
workdays). Overall, 35 substantive items were included into 
the questionnaire and categorized as depicted in table 1. 
The questionnaire is used to determine the self-reported 
confidence in antibiotic prescribing (A, n=4, 4-point Likert-
scale: 1=very unsure, 2=unsure, 3=sure, 4=very sure), self-
reported individual confidence of knowledge on multidrug 
resistance and rational use of antibiotics (B, n=13, 4-point 
Likert-scale: 1=no knowledge, 2= poor to moderate 
knowledge, 3=average knowledge, 4=knowledge above 
average), perception of relevance of potential reasons for 
increasing multidrug resistance (C, n=13, 4-point Likert-
scale: 1=no impact, 2=low impact, 3=moderate impact, 
4=high impact), the personal rationale for a calculated 
antibiotic treatment (D, n=1), participation in training on 
multidrug resistance and rational antibiotic use within the 
last twelve months (E, n=1), frequency of explicit recording 
of multidrug resistant bacteria and potentially needed further 
treatment in medical reports (F, n=1), self-estimated 
prevalence of ciprofloxacin-resistant Escherichia coli at the 
own hospital (G, n=1, specified by <5%, 5-20%, 21-40%, 
41-60%, >60%) and the specific treatment of a 61-year-old 
woman with a heavily symptomatic acute cystitis (H, n=1, 5 
possible answers). In addition to administering the 
questionnaires, the actual ciprofloxacin-resistance of 
Escherichia coli in the participating hospitals was requested 
from the participating centers. 
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Survey administration: 18 German facilities (six university 
medical centers and 12 non-academic tertiary care centers) 
were considered for participation in MR2 after coordination 
with the hospital management boards. Of note, not all 
hospitals provided survey participants from all specialties. 
After hospital recruitment, the heads of departments were 
informed about the study`s aims and were asked to 
participate with their teams.  
Questionnaires were sent out to the participating 
hospitals in August 2015. Survey response was anonymized, 
and questionnaires were only sent once. Using a high-
performance scanner, all questionnaires returned until 
October 1, 2015, were digitalized, and the resulting data 
were separately checked for plausibility by three independent 
collaborators (O.M., H.S. and T.K.).  
These collaborators corrected erroneously the scanned 
data if they were unequivocally verifiable based on the 
original questionnaire.  
These corrections were based on a consensus decision by 
all three collaborators. Datasets were truncated, and 
respective items were treated as missing whenever errors 
within the data could not be excluded. Furthermore, the local 
ciprofloxacin-resistance rates in Escherichia coli were 
requested from the microbiological labs in all participating 
hospitals. 
To characterize the interviewees, 4 items focusing on the 
educational level preceded the survey; further 35 items 
evaluated the following aspects: Individual certainty 
concerning antibiotic prescription, self-assessment of 
knowledge about MDRO and antibiotic prescription, 
classification of MDRO associated issues, individual basis 
for decision-making concerning calculated antibiotic 
prescription, frequency of participation in specific 
educational activities and practical knowledge about ABS 
measures. 
Thus, a total of 39 items were available (4 + 35). 
Questionnaires returned with ≥92% data completeness (≥36 / 
39 items) were accepted for evaluation.  
Statistical analysis: The results of nominally scaled items 
were described using frequencies and proportions, means 
and standard deviations were used for items reported by the 
Likert scale. Specialization was dichotomized into 
‘internists’ vs. ‘non-internists’ (urologists, general surgeons, 
and gynecologists). The distribution of items among these 
groups was assessed by chi-square tests for categorical 
variables and by the Kruskal-Wallis test for continuous 
variables. In addition, four multivariate logistic regression-
models (MLRM) were developed to assess the independent 
influence of the group variable on following dichotomized 
endpoints:  
(1) attendance to theoretical advanced training within the 
last 12 months (≥1 advanced training courses vs. no 
training), (2) self-reported quality of discharge letters 
regarding documentation of MDRO and further clinical 
management (always vs. not always), (3) knowledge of local 
ciprofloxacin-resistance rates in E. coli (correct category vs. 
wrong category according to the predefined 5 categories), 
and (4) guideline-adhering antibiotic therapy in the case 
study (narrow-spectrum antibiotic with/without antibiogram 
or symptomatic treatment vs. other option). If reasonable, 
several possible answers in MLRM were condensed. 
Adjustment of the group variable in MLRM was performed 
according to following criteria: (1) university medical center 
vs. non-academic tertiary care center, (2) hospital hierarchy, 
(3) frequency of antibiotic prescriptions within the 
preceeding seven workdays.  
If useful for improving quality of the model, for each 
endpoint the MLRM was adjusted to the respective other 
predetermined endpoints. The latter was assessed by the 
likelihood-function and Nagelkerke’s R2. Odds ratios (OR) 
and 95% confidence intervals (CI) were used to report the 
influence of different variables on these endpoints. 
Bootstrap-corrected p-values with 1,000 resamples was used 
to test the internal validity.  
Data analysis was performed by the use of SPSS 
(Version 23.0, IBM Corp., Armonk, NY, USA). Two-sided 
statistical significance was defined as a p<0.05. 
 
 
Results 
The response rates in the departments of internal 
medicine, urology, gynecology, and general surgery were 
132/454 (29.1%), 135/176 (76.7%), 33/101 (32.7%) and 
156/330 (47.3%), respectively. Overall, 41.4% of the 
surveyed participants were heads of departments or senior 
physicians, 30.3% consultants, and 28.3% residents. In this 
context, survey responders were heads or senior physicians 
of their departments in 43.9% and 40.4% in the groups of 
internists and non-internists, respectively (P=0.530). 
Internists and non-internists worked in 44.7% and 40.1%, 
respectively, at a university hospital (P=0.402). Within seven 
workdays prior to filling out the questionnaire, internists 
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prescribed antibiotics to >5 patients less often than non-
internists (20.6% vs. 36.9%; P=0.001). The local 
ciprofloxacin-resistance of Escherichia coli in the year 2014 
was median 24% (interquartile range 20-30%) for the 
participating hospitals (n=18). 
There were no significant differences between the two 
groups  in the rates of factors influencing antibiotic 
prescriptions, like national/international or hospital 
guidelines and in the frequency of advanced training in 
MDR, but there was a non-significant trend towards a lower 
rate of internists attending advanced training in comparison 
to non-internists (50.8 vs. 58.6%, P=0.137; fig. 1). Both 
groups demonstrated a low perception pf knowledge in 
respect to ABS (2.00 vs. 1.98, P=0.698) and the concept of 
DART 2020 (1.95 vs. 2.09, P=0.152). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Frequency of continuing medical education 
regarding multi-resistant pathogens (MRP) and 
antibiotic prescription within the last 12 months, 
stratified according to internists vs. non-internists. 
 
Self-reported confidence regarding dosage, frequency, 
duration, administration, and indication was similar between 
internists and non-internists , as was perception of causes of 
relevance for increasing rates of multidrug resistance 
(MDR): Both groups suspected the overuse of broad-
spectrum antibiotics in human medicine (3.50 vs. 3.52, 
P=0.987) to be a critical factor for increasing rates of 
MDRO.  
There were moderate higher rates in the self-reported 
confidence levels in internists compared to non-internists in 
(1) choosing indications for screening patients suspected for 
colonization with methicillin-resistant Staphylococcus 
aureus (MRSA) (3.43 vs. 3.22; P=0.004), (2) initiating 
correct patient specific control measures (3.33 vs. 3.15; 
P=0.002), and (3) in identifying the responsibility to report 
notifiable infectious diseases (2.74 vs. 2.59; P=0.030). 
Furthermore, internists suspected the foreign bodies such as 
Foley catheters significantly more often as risk factors for 
infections (2.96 vs. 2.79; P=0.011). 
However, these small differences did not translate to 
better performance in the management of our test case: 
similar proportions of physicians in both groups (25% vs. 
33.3%, P=0.090) chose a broad-spectrum antibiotic in this 
situation.  
Detailed documentation regarding MDRO and potential 
further outpatient management in hospital discharge letters, 
and knowledge of ciprofloxacin-resistant Escherichia coli 
prevalence in their hospital were also not significantly 
different between these groups (table 1). Heads of 
departments and senior physician internists (OR 3.42, 
p<0.001) and colleagues with more frequent prescription of 
antibiotics (OR 1.91, P=0.005) significantly attended more 
often advanced training courses within the 12-month period 
before the questionnaire was administered. Colleagues who 
underwent advanced training estimated the quality of 
discharge letters of their department by 97% (P=0.010) more 
accurate than their colleagues without advanced training 
during this time period.  
They also had better knowledge of the correct 
Escherichia coli resistance rates to ciprofloxacin in their 
hospital. (OR 1.67, P=0.025). However, a higher attendance 
rate of advanced training did not translate into better 
decision-making in the test case. None of these end points 
were significantly influenced by the group variable (internist 
vs. non-internist) based on multivariate analyses (table 2). 
All results of MLRM were internally valid. 
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Table 1. Differences between internists and non-internists in responding to select items from the MR2 study. 
Item Overall cohort 
(n=456) 
Internists 
(n=132) 
Non-Internists 
(n=324) 
p 
value 
A: Self-reported individual confidence in: 
… the correct choice of dosage, frequency, and duration of 
antibiotics 
3.13 (0.57) 3.12 (0.64) 3.13 (0.53) .846 
… the correct decision regarding the indication of intravenous 
or oral application of antibiotics 
3.21 (0.58) 3.24 (0.62) 3.20 (0.52) .405 
… the correct interpretation of microbiological reports 3.17 (0.56) 3.11 (0.60) 3.20 (0.55) .128 
… the indication of an antibiotic combination therapy 2.72 (0.65)  2.73 (0.67) 2.71 (0.64) .829 
B: Self-reported level of knowledge of: 
… measures of Antibiotic Stewardships (ABS) 1.99 (0.92) 2.00 (0.88) 1.98 (0.93) .698 
… local resistance patterns 2.47 (0.78) 2.43 (0.77) 2.49 (0.78) .412 
… amount of local antibiotic prescribing 2.32 (0.86) 2.35 (0.85) 2.30 (0.86) .514 
… indications of MRSA-screening 3.28 (0.65) 3.43 (0.58) 3.22 (0.67) .004 
… indications of MDRGN-screening 2.89 (0.80) 2.91 (0.81) 2.88 (0.79) .735 
… patient cohorts with need of isolation 3.20 (0.62) 3.33 (0.62) 3.15 (0.61) .002 
… the definitions of 3- and 4-MDRGN 3.25 (0.77) 3.27 (0.77) 3.25 (0.77) .706 
… hygiene measures and hygiene standards in the hospital 3.22 (0.67) 3.25 (0.70) 3.21 (0.66) .470 
… the current rules for hand disinfection. 3.70 (0.48) 3.67 (0.52) 3.72 (0.45) .410 
… the possibilities of success monitoring of sufficient hygiene 
measures and hygiene standards 
2.71 (0.87) 2.73 (0.89) 2.71 (0.86) .619 
… DART 2020, the German Antimicrobial Resistance 
Strategy by the Federal Ministry of Health 
2.05 (0.88) 1.95 (0.84) 2.09 (0.90) .152 
… the responsibility in identifying notifiable infectious 
diseases 
2.63 (0.78) 2.74 (0.77) 2.59 (0.78) .030 
… mixing and cycling of antibiotic treatment regimes 2.14 (0.82) 2.19 (0.79) 2.12 (0.82) .368 
C: Perception of the relevance of increasing MDR: 
Inadequate and excessive use of antibiotics in animal 
husbandry 
3.36 (0.69) 3.38 (0.66) 3.35 (0.70) .752 
Overuse of antibiotics in human medicine 3.54 (0.58) 3.49 (0.64) 3.56 (0.55) .437 
Overuse of broad-spectrum antibiotics in human medicine 3.51 (0.59) 3.50 (0.62) 3.52 (0.57) .987 
Shortened or extended administration of antibiotics in human 
medicine 
3.24 (0.65) 3.19 (0.63) 3.26 (0.65) .278 
Insufficient hand disinfection and hygiene standards amongst 
medical staff 
3.10 (0.78) 3.07 (0.74) 3.11 (0.79) .489 
Insufficient knowledge and guideline-adherence regarding the 
rational use of antibiotics 
3.15 (0.63) 3.14 (0.58) 3.16 (0.66) .769 
Insufficient surveillance measures on the rational use of 
antibiotics 
2.85 (0.71) 2.86 (0.70) 2.84 (0.71) .851 
Insufficient advanced training and no mandatory advanced 
training amongst medical staff 
2.87 (0.73) 2.93 (0.74) 2.84 (0.72) .179 
Too much influence by pharmaceutical companies 2.27 (0.79) 2.29 (0.80) 2.26 (0.78) .866 
Insufficient research activity by pharmaceutical companies on 
novel, potent antibiotics 
2.33 (0.84) 2.43 (0.85) 2.29 (0.84) .148 
Lack of international and global strategies in fighting 2.95 (0.76) 2.87 (0.80) 2.99 (0.74) .168 
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increasing antimicrobial resistances 
Overuse or extended use of foreign bodies (eg. Foley 
catheters), potentially favoring infections 
2.84 (0.70) 2.96 (0.68) 2.79 (0.70) .011 
Lack of trained staff in hospitals and private practices 2.64 (0.76) 2.70 (0.73) 2.61 (0.76) .282 
D: Factors influencing antibiotic prescribing (without antibiogram): 
Official National/International Guidelines 
 
Internal Hospital Guidelines and Hospital Standards 
Colleague advice 
Microbiologist Advice 
No device 
53 (11.6%) 
 
118 (25.9%) 
49 (10.7%) 
27 (5.9%) 
209 (45.8%) 
 24 (18.2%) 
30 (22.7%) 
 
15 (11.4%) 
4 (3.0%) 
59 (44.7%) 
29 (9.0%) 
 
88 (27.2%) 
 
34 (10.5%) 
23 (7.1%) 
150 (46.3%) 
.836
*
 
E: Frequency of advanced training regarding MDRO and antibiotic prescribing in the last 12 months (n=433; n=23 without 
response): 
0 advanced training courses 
 
1 advanced training course 
 
>1 advanced training courses 
189 (43.6%) 
187 (43.2%) 
57 (13.2%) 
62 (49.2%) 
 
47 (37.3%) 
 
17 (13.5%) 
127 (41.4%) 
1 
40 (45.6%) 
 
40 (13.0%) 
.137
**
 
F: Frequency of detailed documentation regarding MDRO and potential further outpatient arrangements in discharge letters: 
Never 
1-49% 
50-99% 
 
100% 
 
Do not know the correct answer 
6 (1.3%) 
68 (14.9%) 
245 (53.7%) 
104 (22.8%) 
33 (7.2%) 
2 (1.5%) 
21 (15.9%) 
66 (50.0%) 
 
31 (23.5%) 
 
12 (9.1%) 
4 (1.2%) 
47 (14.5%) 
179 (55.2%) 
 
73 (22.5%) 
 
21 (6.5%) 
.812 
G: Rates of ciprofloxacin-resistant E. coli strains in the hospital in 2014 (calculated from five categories and matched with the 
actual resistance rates):  
… underestimated 
 
… overestimated 
… correctly estimated 
242 (53.1%) 
65 (14.3%) 
149 (32.7%) 
62 (47.0%) 
 
22 (16.7%) 
48 (36.4%) 
180 (55.6%) 
 
43 (13.3%) 
101 (31.2%) 
.322
***
 
H: Individually chosen clinical pathway in a 61-year old, highly symptomatic female patient with an uncomplicated urinary tract 
infection (n=443) 
Narrow-spectrum antibiotic without antibiogram 
Narrow-spectrum antibiotic with antibiogram 
 
Broad-spectrum antibiotic without antibiogram 
Broad-spectrum antibiotic with antibiogram 
Symptomatic therapy without antibiotic 
73 (16.5%) 
185 (41.8%) 
49 (11.1%) 
88 (19.9%) 
48 (10.8%) 
21 (16.4%) 
56 (43.8%) 
 
9 (7.0%) 
23 (18.0%) 
19 (14.8%) 
52 (16.5%) 
129 (41.0%) 
 
40 (12.7%) 
65 (20.6%) 
29 (9.2%) 
.214 
E. coli: Escherichia coli          MDRGN: multidrug-resistant gram-negative organisms             MRSA: methicillin-resistant staphylococcus aureus 
* 2x2 comparison between ‘one option’ and ‘<no option (no device)’. 
** 2x2 comparison between ‘0 advanced training courses’ and ‘≥1 advanced training courses’. 
*** 2x2 comparison between ‘incorrect answer’ and ‘correct answer’. 
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Table 2. Results of four multivariate logistic regression models evaluating the independent influence of several study 
criteria on predetermined endpoints: (1) attendance of theoretical advanced training courses in the last 12 months (≥1 
advanced training courses vs. no training courses), (2) self-reported quality of discharge letters regarding the 
documentation of MDRO and further outpatient arrangements (always vs. not always), (3) awareness of local 
ciprofloxacin-resistance rates in E. coli strains (correct category vs. wrong category), and (4) guideline-adhering treatment 
course in the case study (narrow-spectrum antibiotic with/without antibiogram vs. other option). [Respective endpoints are 
underlined] 
Criteria OR (95% CI) p 
value 
Bootstrap-corrected p 
value 
Endpoint 1 – Attendance of theoretical advanced training courses in the last 12 months 
Internists vs. Non-Internists 0.73 (0.46-1.14) .169 .196 
University Medical Center vs. Other Option 0.89 (0.59-1.34) .576 .562 
Head of the department and senior physician vs. Other Option 3.42 (2.24-5.23) <.001 .001 
>5 Patients vs. Other Option (Antibiotic prescribing in the last 
seven days) 
1.91 (1.22-3.00) .005 .004 
Endpoint 2 – Self-reported quality of discharge letters 
Internists vs. Non-Internists 1.20 (0.72-2.00) .490 .512 
University Medical Center vs. Other Option 0.87 (0.54-1.39) .549 .556 
Head of the department and senior physician vs. Other Option 1.41 (0.87-2.28) .167 .192 
>5 Patients vs. Other Option (Antibiotic prescribing in the last 
seven days) 
1.33 (0.82-2.18) .253 .275 
≥1 vs. no advanced training in the last 12 months 1.97 (1.18-3.31) .010 .011 
Correct vs. Wrong Category (LECR-Ci) 1.06 (0.65-1.73) .818 .835 
Endpoint 3 – Awareness of local ciprofloxacin-resistance rates in E. coli strains 
Internists vs. Non-Internists 1.42 (0.90-2.22) .132 .127 
University Medical Center vs. Other Option 1.32 (0.87-2.01) .190 .186 
Head of the department and senior physician vs. Other Option 1.49 (0.97-2.29) .070 .082 
>5 Patients vs. Other Option (Antibiotic prescribing in the last 
seven days) 
1.15 (0.73-1.80) .551 .545 
≥1 vs. no advanced training in the last 12 months 1.67 (1.07-2.61) .025 .017 
Endpoint 4 – Guideline-adhering treatment course in the case study 
Internists vs. Non-Internists 1.17 (0.75-1.82) .492 .481 
University Medical Center vs. Other Option 0.80 (0.54-1.20) .285 .298 
Head of the department and senior physician vs. Other Option 0.99 (0.65-1.52) .978 .975 
>5 Patients vs. Other Option (Antibiotic prescribing in the last 
seven days) 
1.05 (0.68-1.63) .830 .825 
≥1 vs. no advanced training in the last 12 months 1.37 (0.90-2.09) .141 .126 
Correct vs. Wrong Category (LECR-Ci) 1.38 (0.89-2.12) .147 .122 
CI: confidence interval;     LECR-CI: local ciprofloxacin-resistance rates in E. coli strains;     MDRO: multidrug-resistant organisms;        OR: odds ratio 
 
Discussion 
The aim of this study was to determine self-assessment of 
competence regarding rational antibiotic use and MDRO and 
to compare these between internists and non-internist from  
various surgical disciplines. Overall, attendance to training 
courses regarding MDRO and antibiotic prescribing was  
 
generally low). Knowledge of local ciprofloxacin-resistance 
rates in Escherichia coli strains was significantly higher for 
physicians, who had taken part in training courses within the 
12 months prior to the survey, which points to a benefit of 
training courses, irrespective of the medical discipline. 
However, the attendance of training did not lead to a 
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significantly better performance in the assessment of the test 
case addressed in the MR2-questionnaire.  
Self-reported knowledge of indications for MRSA 
screening, and indications for specific infection control 
measures for patients colonized with MDRO were slightly 
but significantly higher in internists, compared to their 
surgical counterparts. Although, approximately half of the 
participants in both groups (47.0% of internists as compared 
to 55.6% of non-internists, p=0.099) underestimated the rate 
of Escherichia coli ciprofloxacin-resistance in their hospital. 
This underlines the necessity to improve knowledge of local 
resistance rates. 
Present treatment efforts – and structured ABS training – 
aim at prudent use of broad-spectrum-antibiotics (2). 
However, a large number of physicians in both groups (25% 
vs. 33.6%, P=0.090) would treat the case study patient with 
broad-spectrum antibiotics, where according to current 
guidelines narrow-spectrum antibiotics or even only 
symptomatic therapy would be appropriate (11). While a 
single case study question is probably not sufficient to 
thoroughly compare knowledge of guidelines of antibiotic 
therapy between different specialties, these findings 
nonetheless underline the current deficits in knowledge and 
training, irrespective of specialty (12). This expertise is 
particularly important and warranted for internists as 
infectious diseases is an integral part of internal medicine 
and thus internists should have a broad and current 
knowledge of management of common infectious diseases or 
complications. Furthermore, internists are often consulted by 
colleagues in other specialties for drug therapy in infectious 
diseases (13, 140. Thus, the time has come for all specialties 
and especially for internists to intensify training in the 
management of infectious diseases, especially in the light of 
the current challenge of rapidly rising rates of antibiotic 
resistance. ABS programs should be initiated by hospital 
managers and led by clinicians, and particularly internists, as 
they offer a possibility to shape rules and regulations from 
the physician’s point of view in this important field.  Future 
survey studies should probably include additional test case 
scenarios. These could be based on the “global priority list of 
antibiotic-resistant bacteria to guide research, discovery, and 
development of new antibiotics” published by the World 
Health Organization (WHO) (15). Specific MDRO, such as 
Acinetobacter baumannii, Pseudomonas aeruginosa, and 
Enterobacteriaceae should be given particular priority 
because of their emerging resistance to last resort antibiotics, 
such as carbapenems. Our study has several limitations 
which must be considered when interpreting our findings. 
The response rate of 43% is relatively low and the non-
response-bias might influence our results. Nevertheless, the 
response rate is comparable to other survey studies and the 
evaluated cohorts of hospitals providing all medical 
specialties were homogenous, regardless of differences in 
response rates (5, 6). It might also be possible that 
respondents gave false statements aiming to fulfill certain 
expectations. To mitigate this response bias, questionnaires 
were anonymized. Furthermore, the fact that 44% of the 
respondents did not attend advanced training in the last 12 
months and that only 23% confirmed that all details 
regarding MDRO and further outpatient arrangements are 
provided in the discharge-letters of their department 
indicates honest self-critical and reliable feedback. The 
differences between internists and non-internists were 
significant, but the differences on the Likert scale were 
rather small. The performance rates in the test case and in 
determining the right rate of ciprofloxacin resistance were 
slightly but not significantly higher in internists. Thus it 
cannot be excluded that we did not find better performance 
in the internists although it may have been present, possibly 
due to the small sample size but also due to the size of the 
effect. This study targeted German tertiary care hospitals and 
academic hospitals, and thus might not be generalizable to 
other regions or hospital types. In regard to hospital type, the 
facility type was accounted for in multivariate models to 
mitigate hospital-level biases. Finally, the chosen 
questionnaire items have not yet been validated. Yet, the 
questions were chosen from other surveys and after 
consultation with experts in the field of infectious diseases 
and a pilot study demonstrated the applicability and 
comprehensibility of the survey.  
In conclusion, the data from the MR2-questionnaire 
study presented here indicate that internists do not differ in 
their perception and assessment of issues regarding MDRO 
and antibiotic prescribing as compared to their surgical 
colleagues. This is despite their role as primary caregivers 
for many patients with infectious diseases in an in-patient 
setting. Given the identified deficits in knowledge regarding 
MDRO the data thus underline the need for additional 
advanced MDRO/ABS training for physicians, irrespective 
of their specialty. Mandatory implementation of ABS 
programs in German hospitals could support this training in 
all specialties and raise physician’s awareness and 
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proficiency in antimicrobial treatment. Furthermore, the data 
gained from the MR2-questionnaire study offer the 
possibility to optimize and expand questionnaire design: 
thereby, more detailed evaluation of MDRO and ABS 
knowledge as well as longitudinal assessments prior to and 
after implementation of ABS-based trainings could be 
performed and incorporated into a routine hospital setting.  
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